| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
37,896 |
34,923 |
$2.34M |
| 99215 |
Prolong outpt/office vis |
14,753 |
13,959 |
$1.37M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,675 |
4,651 |
$426K |
| 99205 |
Prolong outpt/office vis |
3,537 |
3,503 |
$423K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,429 |
6,038 |
$198K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,666 |
1,614 |
$181K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,955 |
7,788 |
$103K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,169 |
3,778 |
$98K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,687 |
7,436 |
$73K |
| 71046 |
Radiologic examination, chest; 2 views |
3,438 |
3,295 |
$58K |
| 81025 |
|
5,599 |
5,399 |
$37K |
| 74018 |
|
1,154 |
1,128 |
$18K |
| 73610 |
|
923 |
898 |
$17K |
| 73130 |
|
870 |
838 |
$16K |
| 73630 |
|
905 |
882 |
$16K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,806 |
1,722 |
$14K |
| 81003 |
|
7,244 |
6,997 |
$13K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,119 |
2,070 |
$12K |
| 87428 |
|
376 |
372 |
$10K |
| 86769 |
|
259 |
142 |
$9K |
| 73110 |
|
319 |
306 |
$7K |
| 80053 |
Comprehensive metabolic panel |
758 |
743 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
442 |
436 |
$6K |
| 99000 |
|
895 |
876 |
$6K |
| 93000 |
|
716 |
706 |
$6K |
| 73562 |
|
271 |
257 |
$5K |
| 29515 |
|
131 |
129 |
$5K |
| 12001 |
|
99 |
98 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,996 |
4,767 |
$4K |
| 87807 |
|
378 |
373 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
654 |
641 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,114 |
1,090 |
$2K |
| 90714 |
|
71 |
69 |
$2K |
| 72100 |
|
64 |
64 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
963 |
935 |
$941.19 |
| 10060 |
|
13 |
13 |
$917.99 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
102 |
98 |
$538.58 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
71 |
69 |
$512.01 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
601 |
581 |
$462.48 |
| 73030 |
|
26 |
25 |
$449.11 |
| 74022 |
|
14 |
14 |
$337.52 |
| 73080 |
|
12 |
12 |
$199.68 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
871 |
820 |
$1.81 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
213 |
209 |
$0.00 |